Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 27, 2021
Accession Number: 0001193125-21-017696
Submission Type: POS AM
CIK: 0001731831
Company Name: Eidos Therapeutics, Inc.
File Number: 333-232999